104 related articles for article (PubMed ID: 24370037)
21. Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.
Tiu RV; Gondek LP; O'Keefe CL; Elson P; Huh J; Mohamedali A; Kulasekararaj A; Advani AS; Paquette R; List AF; Sekeres MA; McDevitt MA; Mufti GJ; Maciejewski JP
Blood; 2011 Apr; 117(17):4552-60. PubMed ID: 21285439
[TBL] [Abstract][Full Text] [Related]
22. High-resolution genomic arrays facilitate detection of novel cryptic chromosomal lesions in myelodysplastic syndromes.
O'Keefe CL; Tiu R; Gondek LP; Powers J; Theil KS; Kalaycio M; Lichtin A; Sekeres MA; Maciejewski JP
Exp Hematol; 2007 Feb; 35(2):240-51. PubMed ID: 17258073
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of chromosome karyotype between myelodysplastic syndrome and acute leukemia patients confirmed at the same period].
Jiang M; Wen BZ; Li L; Chen S; Cheng H; Hao JP; Chen R; Wang L; Zhao F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):387-92. PubMed ID: 24763010
[TBL] [Abstract][Full Text] [Related]
24. Detection of TET2 abnormalities by fluorescence in situ hybridization in 41 patients with myelodysplastic syndrome.
Dambruoso I; Boni M; Rossi M; Zappasodi P; Calvello C; Zappatore R; Cavigliano PM; Giardini I; Rocca B; Caresana M; Astori C; Cazzola M; Castagnola C; Bernasconi P
Cancer Genet; 2012 Jun; 205(6):285-94. PubMed ID: 22749034
[TBL] [Abstract][Full Text] [Related]
25. Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes.
Kolquist KA; Schultz RA; Furrow A; Brown TC; Han JY; Campbell LJ; Wall M; Slovak ML; Shaffer LG; Ballif BC
Cancer Genet; 2011 Nov; 204(11):603-28. PubMed ID: 22200086
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.
Wang L; Fidler C; Nadig N; Giagounidis A; Della Porta MG; Malcovati L; Killick S; Gattermann N; Aul C; Boultwood J; Wainscoat JS
Haematologica; 2008 Jul; 93(7):994-1000. PubMed ID: 18508791
[TBL] [Abstract][Full Text] [Related]
27. Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing.
Haferlach C; Bacher U; Tiu R; Maciejewski JP; List A
Cancer Genet Cytogenet; 2008 Dec; 187(2):101-11. PubMed ID: 19027491
[TBL] [Abstract][Full Text] [Related]
28. [Detection of chromosome abnormalities in myelodysplastic syndromes with interval fluorescence in situ hybridization].
Ru X; Li Q; Fang XS; Li Y; Wang X; Zhang LY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):116-20. PubMed ID: 23484703
[TBL] [Abstract][Full Text] [Related]
29. [Improved identification for 5p deletion syndrome and partial trisomy 11q presented in a fetus by SNP array].
Shi S; Pan G; Yang Y; Yan R; Li W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Apr; 33(2):195-9. PubMed ID: 27060314
[TBL] [Abstract][Full Text] [Related]
30. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
MacKinnon RN; Kannourakis G; Wall M; Campbell LJ
Cancer Genet; 2011 Apr; 204(4):187-94. PubMed ID: 21536236
[TBL] [Abstract][Full Text] [Related]
31. Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes.
Gondek LP; Haddad AS; O'Keefe CL; Tiu R; Wlodarski MW; Sekeres MA; Theil KS; Maciejewski JP
Exp Hematol; 2007 Nov; 35(11):1728-38. PubMed ID: 17920760
[TBL] [Abstract][Full Text] [Related]
32. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
[TBL] [Abstract][Full Text] [Related]
33. Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity.
Steensma DP; List AF
Mayo Clin Proc; 2005 May; 80(5):681-98. PubMed ID: 15887439
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment.
Yi JH; Huh J; Kim HJ; Kim SH; Kim SH; Kim KH; Do YR; Mun YC; Kim H; Kim MK; Kim HJ; Kim T; Kim DD
Ann Hematol; 2013 Apr; 92(4):459-69. PubMed ID: 23262795
[TBL] [Abstract][Full Text] [Related]
35. [Karyotype analysis and fluorescence in situ hybridization detection of 122 patients with myelodysplastic syndrome].
Jing Y; Lin S; Jiang F; Wang F; Fang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Apr; 33(2):221-6. PubMed ID: 27060321
[TBL] [Abstract][Full Text] [Related]
36. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.
Kakazu N; Taniwaki M; Horiike S; Nishida K; Tatekawa T; Nagai M; Takahashi T; Akaogi T; Inazawa J; Ohki M; Abe T
Genes Chromosomes Cancer; 1999 Dec; 26(4):336-45. PubMed ID: 10534769
[TBL] [Abstract][Full Text] [Related]
37. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
[TBL] [Abstract][Full Text] [Related]
38. [Multicolor fluorescence in situ hybridization (mFISH].
Michalová K; Zemanová Z; Brezinová J
Cas Lek Cesk; 2001 Mar; 140(4):99-103. PubMed ID: 11284431
[TBL] [Abstract][Full Text] [Related]
39. [Karyotype studies of patients with a myelodysplastic syndrome].
Salamanchuk ZIa; Masliak ZV; Lozyns'ka MR; Vyhovs'ka IaI; Lohins'kyĭ VIe; Male P
Tsitol Genet; 1998; 32(1):43-8. PubMed ID: 9695251
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].
Chen LJ; Li JY; Xiao B; Zhu Y; Liu Q; Pan JL; Qiu HR; Fan L; Zhang SJ; Lu RN; Xu W; Xue YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):635-9. PubMed ID: 18067073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
